Literature DB >> 14728436

Impact of CPOE order sets on lab orders.

Hagop Mekhjian1, Joel Saltz, Patrick Rogers, Jyoti Kamal.   

Abstract

Introduction of the computerized physician order (CPOE) is intended to promote best practices, decrease practice variation among practitioners, and optimize the utilization of resources consistent with evidence based practice guidelines. Implicit in the use of CPOE is the assumption that the use of order sets might decrease utilization of resources such as the ordering of unnecessary laboratory tests. Conversely compliance with practice guidelines may necessitate ordering of certain tests that are deemed to be consistent with the good practice of medicine. In order to develop an understanding of these issues, we compared the utilization of laboratory orders prior to and following implementation of order sets in CPOE. In addition, we analyzed the impact of CPOE on the timely placement of certain orders based on critical levels of some laboratory results, in this instance potassium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14728436      PMCID: PMC1480063     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  3 in total

1.  The use of count data models in biomedical informatics evaluation research.

Authors:  Jing Du; Young-Taek Park; Nawanan Theera-Ampornpunt; Jeffrey S McCullough; Stuart M Speedie
Journal:  J Am Med Inform Assoc       Date:  2011-06-29       Impact factor: 4.497

2.  Creation and Use of an Electronic Health Record Reporting Database to Improve a Laboratory Test Utilization Program.

Authors:  Danielle E Kurant; Jason M Baron; Genti Strazimiri; Kent B Lewandrowski; Joseph W Rudolf; Anand S Dighe
Journal:  Appl Clin Inform       Date:  2018-07-11       Impact factor: 2.342

3.  Impact of computerized provider order entry (CPOE) on length of stay and mortality.

Authors:  Ann M Lyons; Katherine A Sward; Vikrant G Deshmukh; Marjorie A Pett; Gary W Donaldson; Jim Turnbull
Journal:  J Am Med Inform Assoc       Date:  2017-03-01       Impact factor: 4.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.